James W. Murrough
Affiliations: | Psychiatry | Icahn School of Medicine at Mount Sinai, New York, NY, United States |
Google:
"James Murrough"Mean distance: (not calculated yet)
Children
Sign in to add traineeJaclyn S Kirshenbaum | research assistant | 2013-2016 | Icahn School of Medicine at Mt Sinai, New York |
Morgan B Corniquel | research assistant | 2018-2021 | Mount Sinai School of Medicine |
Aaron D Z Tan | grad student | 2017- | Mount Sinai School of Medicine |
Nicholas Thomas Van Dam | post-doc | 2015-2017 | Mount Sinai School of Medicine |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
McIntyre RS, Alsuwaidan M, Baune BT, et al. (2023) Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 22: 394-412 |
Yang EJ, Frolinger T, Iqbal UH, et al. (2023) The Bioactive Dietary Polyphenol Preparation Alleviates Depression and Anxiety-Like Behaviors by Modulating the Regional Heterogeneity of Microglia Morphology. Molecular Nutrition & Food Research. e2300156 |
Anand A, Mathew SJ, Sanacora G, et al. (2023) Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. The New England Journal of Medicine |
Yang EJ, Frolinger T, Westfall S, et al. (2023) The bioactive dietary polyphenol preparation alleviates depression and anxiety-like behaviors by modulating the regional heterogeneity of microglia morphology. Biorxiv : the Preprint Server For Biology |
Alper J, Feng R, Verma G, et al. (2023) Stress-related reduction of hippocampal subfield volumes in major depressive disorder: A 7-Tesla study. Frontiers in Psychiatry. 14: 1060770 |
Hock RS, Feeney A, Iovieno N, et al. (2022) Rapidity of Symptom Improvement With Intranasal Esketamine for Major Depressive Disorder: A Systematic Review and Meta-Analysis. The Journal of Clinical Psychiatry. 84 |
Issler O, van der Zee YY, Ramakrishnan A, et al. (2022) The long noncoding RNA FEDORA is a cell type- and sex-specific regulator of depression. Science Advances. 8: eabn9494 |
Price RB, Kissel N, Baumeister A, et al. (2022) International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators. Molecular Psychiatry |
Bloomfield-Clagett B, Ballard ED, Greenstein DK, et al. (2022) A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Non-Suicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine. The International Journal of Neuropsychopharmacology |
Evers AG, Murrough JW, Charney DS, et al. (2022) Ketamine as a prophylactic resilience-enhancing agent. Frontiers in Psychiatry. 13: 833259 |